The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22318237.
- Also identified by DOI 10.1038/nrc3214 and PMC identifier 3322353.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.
Medical subject headings
- Neoplasms
- Peroxisome Proliferator-Activated Receptors